Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Vantrela ER in Chronic Pain
NCT01223365Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in chronic pain, sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2010; status: completed.
02
Drugs
bupropion
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01223365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223365.